ANTHONY RODRIGUEZ: Open Payments
NPI 1770020521 · WARREN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 18 payments from 8 companies in 2025. Trend: 2023 $379 · 2024 $524 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $162 |
| ABBVIE INC. | 5 | $107 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: AIRSUPRA, FARXIGA, VRAYLAR, QULIPTA, Auvelity, HETLIOZ, CAPLYTA, Ozempic.
Industry payments across AR — which companies pay providers there.
